Chicago Cubs pitcher Jon Lester, left, and catcher Anthony Rizzo get their new injector for the 2016 season, on the field on Aug. 27, 2017, in Chicago.
The Cubs have agreed to pay $14.9 million for an injection machine that will allow them to inject players with around 30 million times more than normal during games.
The deal was reached after several months of negotiations with several players and teams.
The deal also includes the delivery of a new injectable line called the Desma, which is used for minor league pitchers.
Chicago is getting the new injecters in order to increase its capacity for high-level players.
We want to increase the quality of our players in this league, and the ability to get those players on the ball at a faster pace,” Cubs president Theo Epstein said in a statement.
Players who use injectors to inject are typically called “pitchers.”
In addition to increasing their chances to hit, pitchers will also be able to increase their productivity. “
We know that it’s important for us to keep our pitchers healthy and playing,” Cubs manager Joe Maddon said.
In addition to increasing their chances to hit, pitchers will also be able to increase their productivity.
While it has been a long time coming, the Cubs are finally getting their injectors.
The injectors are scheduled to be on the market by early October.